Written by Ardis M. Copenhaver, PharmD, MS, BCPS Some of Medicare Part D changes from the passage of Inflation Reduction Act of 2022 have come into effect in January 2025. The goal of this legislation is to provide further support on prescription drug benefits for the adults aged 65 and older and those individuals with qualifying disabilities. The two big 2025 changes include the elimination of the “Donut Hole” with the reduction of out-of-pocket (OOP) costs and the launch of

Written by Ally Rhea, PharmD Candidate 2027; Sai Wright, PharmD, MBA, MSPH; Laurel Uhomba, PharmD, MBA, MPH Nearly 12 million adults over the age of 40 in the United States are living with vision loss, which may significantly impact their ability to manage medications safely.(1) Prescription labels are often printed in small fonts that are not accessible to visually impaired individuals. Without the ability to read medication names, instructions, or warnings, patients may fa

By Sarah Rinehart, PharmD, BCACP Patients with inflammatory bowel disease (IBD) are often treated with biologics or small molecules, including tumor necrosis factor (TNF)–α antagonists and corticosteroids.(1,2)  Patients on these regimens with latent tuberculosis infection (LTBI) are at risk for reactivation of Mycobacterium tuberculosis  to active tuberculosis (TB) disease.(3) Screening for LTBI using either   TB blood tests (Interferon Gamma Release Assays [IGRAs] including

By Alexis Richardson, PharmD Candidate and Adenike Atanda-Oshikoya, PharmD, BCACP, CDCES It is estimated that 20% of adults in the United States experience mental health conditions every year, and 46% of adults aged 18 or older with any mental illness (AMI), received inpatient or outpatient mental health services or took prescription medication to treat a mental health condition in the last year.(1) These conditions include anxiety disorders, depression disorders, attention d

By Dave Ferris, PharmD Hypertrophic Obstructive Cardiomyopathy (HOCM) is a devastating disease and, until recently, had no treatment.  With the introduction of mavacamten, symtoms not only improve but disease progression can be reversed.  This medication poses significant drug interactions and possible complications.  With  medication-related expertise,  pharmacists have the opportunity to improve patient safety and care for patients with HOCM who initiate this therapy . The

By Hannah Vitale, PharmD Candidate 2024 and Kimmy Nguyen, PharmD, BCACP, BC-ADM, TTS Introduction In the US, there are over 1,400...

By Zach Krauss, PharmD and Sarah Leupold, PharmD Hepatitis C Virus (HCV) is a viral infection that causes liver inflammation, sometimes...

By Cassie Heffern, PharmD, BCACP I’ve worked within a family medicine residency clinic that serves a largely medically underserved...

By Kate Cozart, M.Ed., Pharm.D., BCPS, BCGP, BCACP; Aleia Judd, Pharm.D., BCACP; and Dr. Paula Newberry, Pharm.D., BCPS, BCGP, BCACP...